Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depression; Bipolar Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03641300
What this trial is testing

Efficacy of Convulsive Therapies for Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Centre for Addiction and Mental Health 76
Not applicableStudy completedNCT02150577
What this trial is testing

Implementation Trial of Evidence Based Practices for Mood Disorders

Who this might be right for
Bipolar DisorderTreatment Resistant Depression
University of Arkansas 291
Not applicableStudy completedNCT05747612
What this trial is testing

Mental Coaching and Counseling for Bipolar Patients: Dealing With Moments of Crisis in Times of COVID-19.

Who this might be right for
To Determine the Incidence of Depression in Subjects Affected by Bipolar Disorder
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Post-approval studies (Phase 4)Ended earlyNCT02389712
What this trial is testing

16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression

Who this might be right for
Bipolar Disorder
Mayo Clinic 2
Large-scale testing (Phase 3)Looking for participantsNCT07172516
What this trial is testing

Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Xenon Pharmaceuticals Inc. 400
Not applicableNot Yet RecruitingNCT07510646
What this trial is testing

Transcranial Photobiomodulation for Bipolar Depression

Who this might be right for
BipolarBipolar Disorder (BD)Bipolar Disorder Depression
Vielight Inc. 40
Not applicableUnknownNCT02404662
What this trial is testing

Trial of Supportive Text Messages for Patients With Alcohol Use Disorder and a Co-morbid Depression

Who this might be right for
Dual Diagnosis
St Patrick's Hospital, Ireland 107
Testing effectiveness (Phase 2)Ended earlyNCT01784666
What this trial is testing

Adjunctive Isradipine for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Disorder
Massachusetts General Hospital 2
Large-scale testing (Phase 3)Study completedNCT00868452
What this trial is testing

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Who this might be right for
Bipolar Depression
Sumitomo Pharma America, Inc. 348
Testing effectiveness (Phase 2)WithdrawnNCT00447096
What this trial is testing

RTMS for Treatment of Depressed Phase of Bipolar Disorder Type II

Who this might be right for
Bipolar Disorder
University of Texas Southwestern Medical Center
Post-approval studies (Phase 4)Study completedNCT00227968
What this trial is testing

Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder

Who this might be right for
Bipolar Disorder
University of Pittsburgh 181
Large-scale testing (Phase 3)Study completedNCT00483548
What this trial is testing

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Who this might be right for
Bipolar DisorderDepression, Bipolar
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 298
Post-approval studies (Phase 4)Study completedNCT01168674
What this trial is testing

Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder

Who this might be right for
DepressionBipolar Disorder
Tufts Medical Center 49
Post-approval studies (Phase 4)Study completedNCT00223197
What this trial is testing

Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse

Who this might be right for
Bipolar DisorderMajor Depressive DisorderSubstance Abuse
University of Texas Southwestern Medical Center 75
Post-approval studies (Phase 4)Study completedNCT03156504
What this trial is testing

The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.

Who this might be right for
Major DepressionBipolar I DisorderBipolar II Disorder+1 more
Mayo Clinic 75
Post-approval studies (Phase 4)Study completedNCT00294255
What this trial is testing

Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania

Who this might be right for
Bipolar Disorder
The University of Texas Health Science Center at San Antonio 45
Testing effectiveness (Phase 2)Study completedNCT00719706
What this trial is testing

The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder

Who this might be right for
Bipolar Depression
Mclean Hospital 40
Not applicableStudy completedNCT00186485
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression

Who this might be right for
Bipolar Disorder
Stanford University 28
Not applicableEnrolling By InvitationNCT07783633
What this trial is testing

Identifying Biomarkers of Response to Digital Interventions for Mood Disorders

Who this might be right for
Depression / Major Depressive DisorderBipolar Disorder (BD)
Centre for Addiction and Mental Health 200
Post-approval studies (Phase 4)Ended earlyNCT01051440
What this trial is testing

Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression

Who this might be right for
Bipolar Depression
Steward St. Elizabeth's Medical Center of Boston, Inc. 2
Next Page